NCT01881048 2026-01-29
Window of Opportunity Study Targeting the Inflammatory Milieu
University of Colorado, Denver
Phase EARLY_PHASE1 Completed
Clinical Trials
24 trialsNCT01351805 2025-12-03
VITAL
Brigham and Women's Hospital
Phase NA Completed
NCT00244816 2025-10-23
Taxoprexin® Treatment for Advanced Eye Melanoma
American Regent, Inc.
Phase 2 Completed
NCT00249262 2025-09-26
Taxoprexin Treatment for Advanced Skin Melanoma
American Regent, Inc.
Phase 2 Completed
NCT00243867 2025-08-01
Taxoprexin Plus Carboplatin Treatment for Advanced Lung Cancer
American Regent, Inc.
Phase 3 Completed
NCT04116203 2025-02-28
PCOS
University of Alberta
Phase 1 Completed
NCT06339372 2024-04-02
Perioperative Supplementation With Immunonutrition and Its Impact on Surgical Outcome and Pain in Oral Cavity or Mandibular Tumours
Cairo University
Phase NA Completed
NCT02538484 2023-07-17
Impact of Omega 3 Fatty Acid Supplementation on Aromatase in Obese Subjects
The University of Texas Health Science Center at San Antonio
Phase EARLY_PHASE1 Completed
NCT02831582 2023-02-27
Omega-3 Supplementation in Prevention of Aromatase Inhibitor-Induced Toxicity in Patients With Stage I-III Breast Cancer
Ohio State University Comprehensive Cancer Center
Phase NA Completed
NCT03598413 2022-09-28
PROTEIN
Royal Surrey County Hospital NHS Foundation Trust
Phase NA Completed
NCT02278965 2022-08-17
Metformin and Omega-3 Fatty Acids in Woman With a History of Early Stage Breast Cancer
Columbia University
Phase 1 Completed
NCT02517502 2022-01-24
Docosahexaenoic Acid (DHA) To Prevent Development of Cognitive Dysfunction Due to Chemotherapy
University of Kansas Medical Center
Phase EARLY_PHASE1 Completed
NCT01733147 2022-01-11
Modulation of Esophageal Inflammation in Barrett's Esophagus by Omega-3 Fatty Acids
Mayo Clinic
Phase 4 Completed
NCT01849250 2021-12-28
Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer Survivors
National Cancer Institute (NCI)
Phase 2 Completed
NCT03093207 2020-11-17
Omega-3 Fatty Acids Plus Low-dose Aspirin Daily Supplementation in Surgical Therapy to Treat Aggressive Periodontitis
Universidade Estadual Paulista Júlio de Mesquita Filho
Phase 2/3 Completed
NCT03290417 2020-02-18
Correlative Analysis of the Genomics of Vitamin D and Omega-3 Fatty Acid Intake in Prostate Cancer
Case Comprehensive Cancer Center
Phase NA Completed
NCT02352779 2017-08-08
Omega-3 Fatty Acid in Reducing Cancer-Related Fatigue in Breast Cancer Survivors
University of Rochester
Phase NA Completed
NCT02779868 2017-07-25
Omega-3 Supplementation in Cervix Cancer Patients Undergoing Chemoradiotherapy
Brazilian National Cancer Institute
Phase NA Completed
NCT00253643 2017-04-18
Fish Oil and Green Tea Extract in Preventing Prostate Cancer in Patients Who Are at Risk for Developing Prostate Cancer
OHSU Knight Cancer Institute
Phase NA Completed
NCT00815685 2017-03-23
A Pilot Study of Eicosapentaenoic Acid (EPA) in Patients With Cancer Cachexia
H. Lee Moffitt Cancer Center and Research Institute
Phase NA Completed
NCT01051154 2016-08-22
DHA-ALL
Coordinación de Investigación en Salud, Mexico
Phase 2 Completed
NCT01032343 2013-08-22
An Immunonutritional Approach to the Prevention of Skin Cancer
University of Manchester
Phase NA Completed
NCT01070355 2011-10-21
EMT
University of Leeds
Phase 2 Completed
NCT00146211 2007-12-27
TREND-HD - A Trial of Ethyl-EPA (Miraxionâ„¢) in Treating Mild to Moderate Huntington's Disease
Amarin Neuroscience Ltd
Phase 3 Completed